Legal Opinion
Massachusetts v. Mylan Laboratories
District Court, D. Massachusetts
Decided February 4, 2005No. CIV.A.03-11865-PBSPublishedCited by 39 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
SARIS, District Judge.
I. INTRODUCTION
The Commonwealth of Massachusetts brings this case against thirteen Defendant pharmaceutical manufacturers for their alleged role in causing Massachusetts to overpay pharmacies and other providers for generic prescription drugs under the Commonwealth’s .Medicaid Program by fraudulently inflating the ‘Wholesale Acquisition Cost” (“WAC”) of covered drugs. 1 Massachusetts also alleges that Defendants reported false prices to the federal Secretary of Health and Human Services (“HHS”) under the Best Prices rebate program, depriving…
2Cases cited40 opinions
- Morissette v. United StatesSupreme Court of the United States · 1952
- Alexander v. SandovalSupreme Court of the United States · 2001
- Morales v. Trans World Airlines, Inc.Supreme Court of the United States · 1992
- Harris v. McRaeSupreme Court of the United States · 1980
- Boyle v. United Technologies Corp.Supreme Court of the United States · 1988
35 more not listed; retrieve them via the Exa API.
3Cited by39 opinions
- Massachusetts Eye & Ear Infirmary v. QLT Phototherapeutics, Inc.Court of Appeals for the First Circuit · 2009
- In re Pharmaceutical Industry Average Wholesale Price LitigationDistrict Court, D. Massachusetts · 2005
- Markle v. HSBC Mortgage Corp. (USA)District Court, D. Massachusetts · 2011
- Carlin v. DairyAmerica, Inc.Court of Appeals for the Ninth Circuit · 2012
- State v. HardenSupreme Court of Florida · 2006
34 more not listed; retrieve them via the Exa API.